Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Spectral Medical Inc.TSX: EDT.TO

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 293.23M shares rose 3.0% year over year, ahead of the +2.4% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +2.1% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +3.0% holds above the trailing-twelve-month pace of +2.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
293.23M+0.5% QoQ
Last fiscal yearDec 2025
287.21M+2.2% YoY
LTMMar 2026
289.2M+2.4% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.0%——
1 year+2.2%——
3-year CAGR+2.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
287.21M CAD
Year-over-year change
+2.2%
4-year CAGR
+3.3%

Weighted Avg Shares (Diluted) vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • EDT.TO's LTM Mar 2026 weighted avg shares (diluted) of 289.2M shares is the highest of the 8 companies compared; the peer median is 45.37M shares.
  • Its year-over-year change of +2.4% is the lowest of 8, against a peer median of +11.5%.
  • Over three fiscal years its annual growth of +2.1% compares with a peer median of +8.4%.
EDT.TO Competitors Peer median
Weighted Avg Shares (Diluted) for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR
EDT.TOSpectral Medical Inc.LTM Mar 2026289.2M +2.4%+2.1%
WEED.TOCanopy Growth CorporationLTM Mar 2026288.35M +167.7%+8.4%
KSI.TOKneat.com, Inc.LTM Mar 202695.31M +5.0%+7.0%
ACB.TOAurora Cannabis Inc.LTM Mar 202656.7M +3.3%+20.7%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 202645.37M +27.3%+27.5%
PRN.TOProfound Medical Corp.LTM Mar 202631.8M +21.4%+13.3%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 202630.57M +11.5%+2.8%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202626.09M +3.3%+0.5%
Peer median (excluding EDT.TO) 45.37M+11.5%+8.4%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2M1.67M1.6M2.29M2.44M
Cost of Revenue832K684K936K1.27M7.6M
Gross Profit1.16M983K662K1.02M(5.16M)
Gross Margin58.3%59.0%41.4%44.5%-211.1%
Research & Development004.68M3.97M4.33M
Selling, General & Admin7.01M8.64M11.29M11.62M11.73M
Operating Expenses7.86M9.43M12.08M13.02M6.53M
Depreciation & Amortization294K272K218K251K250K
EBITDA(6.38M)(7.18M)(13.96M)(11.97M)(11.44M)
EBITDA Margin-319.4%-430.7%-873.3%-523.5%-468.3%
Operating Income(6.66M)(8.45M)(11.42M)(12M)(11.69M)
Operating Margin-333.5%-506.7%-714.7%-524.8%-478.5%
Interest Income00005.39M
Interest Expense28K176K1.33M3.18M5.16M
Other Income / Expenses(40K)819K(4.09M)(3.4M)(36M)
Income Before Tax(6.96M)(7.63M)(15.51M)(15.4M)(47.69M)
Pre-Tax Margin-348.6%-457.6%-970.4%-673.4%-1952.9%
Income Tax Expense00000
Net Income(8.79M)(11.28M)(15.66M)(15.4M)(47.69M)
Net Margin-440.1%-676.7%-980.1%-673.8%-1953.0%
EPS (Basic)(0.03)(0.04)(0.06)(0.05)(0.17)
EPS (Diluted)(0.03)(0.04)(0.06)(0.05)(0.17)
Weighted Avg Shares252.46M269.84M278.56M281.08M287.21M
Weighted Avg Shares (Diluted)252.46M269.84M278.56M281.08M287.21M

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.